All posts by imreal

Vyne Dental Hosts Webinar with Teresa Duncan to Announce CDT Coding Update


News Image

When you understand the context, the changes aren’t so frightening. The most important thing is not to freak out,” says Teresa Duncan.

Teresa’s first major goal is to spread awareness about the incoming changes. “There are 22 new codes, 14 revisions, and 2 code deletions,” she says. Using obsolete codes will lead to frustrating delays. Teresa will explain the additions, deletions, and revisions in context, so dental billers can see how each fits into the evolving insurance landscape.

But there’s more to the updated webinar than the basic numbers. “Some of the biggest changes have to do with guided tissue regeneration, full mouth radiographs, and full mouth debridement. I’ll focus on what those imply for the practice in general.” Both the administrative and clinical staff have obligations to ensure claims are properly submitted, so Teresa will also share best practices to bring the whole team, front-office and back-office, up to speed.

Teresa will touch on the proliferation of Medicare Advantage plans, and what that might mean for your practice. She’ll also explore the current legislative environment, and the implications it might have for insurance in both the short and long term. “It’s important to know what could be coming to a Congress near you,” she says.

With years of experience, Teresa is able to discern larger trends and sift out granular detail. “Carriers are much more specific than they were before,” she explains. “That can be problematic for us, on the administrative side. But when you understand the context, the changes aren’t so frightening. The most important thing is not to freak out.”

The CDT Coding Update is always in high demand. Register today for your chance to attend this complimentary webinar hosted by Vyne Dental, and ensure your practice is on track for 2023 right from the very beginning.

Date: Tuesday, January 10, 2023, at 1 pm ET

Register today!

https://register.gotowebinar.com/register/2915254346796558607?source=press

© 2022 Napa EA/MEDX, LLC. All rights reserved All third-party trademarks and tradenames (including logos and icons) referenced are and remain the property of their respective owners.

This webinar is part of a joint program with Vyne Dental and has been prepared for informational purposes only. Vyne Dental does not guarantee reliance on the aforementioned information. For verification, please seek counsel from an appropriate legal or agency professional. The opinions and views expressed in the webinar are the opinions of the designated presenters and do not reflect the opinions or views of Vyne Dental.

Hyperlinks included are provided for convenience and may lead to resources located on servers maintained by other persons or organizations. Vyne Dental is not responsible for the privacy practices of third-party websites.

Share article on social media or email:

Announcing the Winners of The Scientist’s Top 10 Innovations of 2022


The Scientist Top 10 Innovations

The Scientist Top 10 Innovations

The Scientist is a publication for life science professionals that is dedicated to covering a wide range of biological fields.

Each year The Scientist highlights the latest and greatest tools, technologies, and techniques to hit the life science landscape. For more than a decade, we’ve been employing the assistance of expert panels of independent judges who weigh submissions of innovative products that are speeding work in laboratories and facilitating biological discovery.

This year’s crop of entries to The Scientist’s Top 10 Innovations contest included many with a clinical focus, and others that represent significant advances in sequencing, single-cell analysis, and more. The winners that emerged reflect the fact that the research enterprise continues to hum along as the world emerges from the worst that SARS-CoV-2 threw at us.

The winners of The Scientist’s Top 10 Innovations of 2022 contest are:

1. NeXT PersonalTM (Personalis): A personalized assay that detects, quantifies, and monitors circulating tumor DNA in order to spot molecular residual disease following surgical removal and track responses to therapy

2. CosMxTM Spatial Molecular Imager (NanoString Technologies): A product that visualizes and quantifies RNA and protein levels at the single-cell and even subcellular levels, and allows researchers to image multiple targets in one sample

3. UG100TM (Ultima Genomics): Technology that can sequence an entire human genome for US$100, and also boasts higher speed, better efficiency, and less waste than other sequencers, according to the company

4. ProteographTM Product Suite (Seer): A nanoparticle-based assay that allows unbiased sampling of all peptides in a biofluid sample, allowing researchers to track small molecular changes associated with disease and enabling the identification of novel and biologically relevant proteoforms

5. Live T Cell Assay (Nanolive): An application-specific digital assay that examines how T cells locate, bind, stress, and kill their targets, such as infected, foreign, or cancerous cells

6. MARS® Bar (Applied Cells, Inc.): A closed system that selects cells based on the presence of specific cell surface antigens and is not limited to use in a clean room or biosafety cabinet

7. Single Cellome™ System SS2000 (Yokogawa Electric Corporation): An automated subcellular sampling system that contains both a dual spinning-disk confocal microscope to visualize tissues and a sampling setup to collect either whole cells or intracellular components from a single cell

8. LightBench® Detect (Yourgene Health): A DNA processing tool that separates fragments by length for applications such as noninvasive prenatal testing, which involves analyzing fetal DNA collected from the mother’s blood

9. Molecular Cartography™ (Resolve Biosciences): A single-molecule fluorescence in situ hybridization technology that offers a three-dimensional view of gene expression within cells without damaging the tissue section or cell culture sample

10. OCELLOS 3.0 (TrakCel): A cloud-based software that tracks cell and gene therapies from extraction or manufacturing to the moment they’re administered to a patient, managing the chain of identity and chain of custody data that regulatory agencies require

Congratulations to this year’s winners. Be sure to visit the online feature where you can read more about the products that earned top spots and see comments from our expert judges.

About The Scientist:

The Scientist is a publication for life science professionals that is dedicated to covering a wide range of biological fields. The Scientist provides print and online coverage of the latest developments in the life sciences, including trends in research, new technology, news, business, and careers. It is read by the science-curious public and leading researchers in industry and academia who value penetrating analyses and broad perspectives on life science topics both within and beyond their areas of expertise. Written by prominent scientists and professional journalists, articles in The Scientist are concise, accurate, accessible, and entertaining.

Share article on social media or email:

Oxford Performance Materials and Jajal Medical Combine Core Technologies to address Large Bone Defect Orthopedic Cases


Oxford Performance Materials, Inc. (OPM; https://oxfordpm.com/), an industry leader in advanced polymer science, coating technologies, and 3D-printed biomedical devices, and Jajal Medical, a leader in 3D visualization and digital planning, are collaborating to deliver a fully integrated solution for patients with major bone defects requiring customized orthopedic implants. This new partnership combines Jajal’s 3D Surgical® digital planning platform with OPM’s 3D printing OsteoFab® PEKK technology to address a growing, unmet need for patient-specific high performance polymer implants, worldwide. The initial application for these combined technologies will address war trauma cases in Ukraine over the coming weeks.

Large segmental defects result from musculoskeletal tumors, infections, and trauma; since each instance is unique, surgeons require implants designed & manufactured on a case-by-case basis. OPM is a pioneer in this area, first delivering patient-specific craniomaxillofacial (CMF) implants in 2013 with the launch of its OsteoFab PEKK implant technology. Jajal’s 3D visualization & digital planning software suite is an ideal platform for design of complex surgical cases, and Jajal’s expert team will be managing the design function for these custom 3D printed implant cases.

“This unique partnership with Jajal Medical creates an end-to-end solution that is unparalleled in today’s orthopedic landscape,” said OPM CEO Scott DeFelice. “OPM has identified a clear market need for custom critical bone defects in the U.S. and abroad that are not supported – economically or clinically – at this time. By marrying Jajal’s design capabilities with OPM’s patented PEKK material science and 3D printing technology, we will offer solutions that improve clinical outcomes at lower overall cost.”

CEO Ketan Jajal responded: “We originally developed the 3D Surgical digital planning platform with partners like OPM in mind. Each custom orthopedic implant case is, in effect, a partnership between the surgeon, the design team and the manufacturer. The 3D Surgical platform fully streamlines communication, workflow, and makes customization scalable. When combined with OPM’s metal-free material technology – which is osseointegrative and antibacterial with proven mechanical performance – we hope together to offer a “best of” solution for today’s global market.”

In September, OPM announced a major effort to support OHFU, a Ukranian non-profit aiding bone trauma war casualty cases. The first step in the OPM-Jajal partnership will contribute to these efforts in Ukraine. Specifically, OPM has signed a custom manufacturing agreement with a Ukrainian healthcare organization. Jajal is designing large bone defect implants for the cases that will be manufactured by OPM and shipped directly to the Ukrainian surgeons. From there, the OPM – Jajal partnership will be teaming up with OEMs toward regulatory clearances and distribution to hospitals and surgeons treating major bone defect cases throughout the world.

About Oxford Performance Materials, Inc.

Oxford Performance Materials, Inc. was founded in 2000 to exploit and commercialize the world’s highest performing thermoplastic, PEKK (poly-ether-ketone-ketone). OPM’s Materials business has developed a range of proprietary, patented technologies for the synthesis and modification of a range of PAEK polymers that are sold under its OXPEKK® brand, including coating technologies for a range of industrial and biomedical applications. OPM is a pioneer in 3D printing. OPM’s OsteoFab® technology is in commercial production in numerous orthopedic implant applications, including cranial, facial, spinal, trauma and sports medicine devices. OPM’s OXFAB® production parts are designed for highly demanding industrial applications.

For Inquiries to Oxford Performance Materials:

Bernard Plishtin

Oxford Performance Materials, Inc.

917.494.3649

bplishtin@oxfordpm.com

About Jajal Medical and 3D Surgical

Jajal Medical Services was founded in 2019 to democratize 3D printing in complex surgery. Jajal has developed expertise in Preoperative Planning for patient specific surgery in orthopedics, including Cranio-Maxillofacial, Bone Oncology and Joint Arthroplasty. Jajal’s unique 3D Surgical® digital planning platform allows medical device companies and hospitals easily integrate 3D printing into their current workflow. Jajal is pioneer in designing clinically relevant patient specific products with high complexity.

For Inquiries to Jajal Medical:

Arpan Saluja

Jajal Medical Services

302.549.2288

Arpan.saluja@jajalmedical.com

Share article on social media or email:

American Pharmaceutical Review and Pharmaceutical Outsourcing Release Documentary on Cell and Gene Therapies


American Pharmaceutical Review and Pharmaceutical Outsourcing Release Documentary on Cell and Gene Therapies.

American Pharmaceutical Review and Pharmaceutical Outsourcing Release Documentary on Cell and Gene Therapies.

Cell and gene therapies offer hope to many individuals for which current treatments have proven unsuccessful.

American Pharmaceutical Review, the leading review of business and technology for the pharmaceutical industry throughout North America and Pharmaceutical Outsourcing magazine a journal dedicated to pharmaceutical and biopharmaceutical contract services that provides the most complete coverage of trends and issues in the industry have released their documentary on “Cell and Gene Therapy: Advancing the Next Generation of Pharmaceuticals”. The goal of the documentary is to examine how cell and gene therapies, which fall into the broader category of drugs known as Advanced Therapy Medicinal Products (ATMPs) have emerged as an incredibly promising class of treatments that have shown the ability to treat and even cure many individuals with diseases for which there was little to no hope.

The documentary features commentary and outlook from key opinion leaders representing regulatory, industry, and technology providers who offer their thoughts and outlook on the current state of cell and gene therapy development, manufacturing, and distribution.

“Cell and gene therapies offer hope to many individuals for which current treatments have proven unsuccessful. But, as with most cutting-edge technologies there are many issues to sort out.” says Mike Auerbach, Editor in Chief, American Pharmaceutical Review and Pharmaceutical Outsourcing. “In this video documentary we explore where the industry is in terms of developing cell and gene therapies, current and future technologies, and what the regulatory environment is for these promising treatments.”

The market outlook for cell and gene therapies is expected to grow in the coming years. According to Research and Markets report ” Cell & Gene Therapy Market – Global Outlook & Forecast 2022-2027”, the cell and gene therapy market size was valued at USD 4.99 billion in 2021 and is expected to reach USD 36.92 billion by 2027, growing at a CAGR of 39.62 % during the forecast period. The report goes on to mention that “Increasing application of gene therapies in diseases diagnosis and rapidly growing new drugs applications will give new market space in upcoming years. In 2020, around USD 2.3 billion funding was reported only from private companies for gene therapies. By 2025, the FDA is expected to approve 10−20 products each year, driving the global cell and gene therapy manufacturing market.”

For more information on this documentary on Cell and Gene Therapy: Advancing the Next Generation of Pharmaceuticals please visit: https://www.americanpharmaceuticalreview.com/Cell-and-Gene-Therapy/.

About American Pharmaceutical Review

American Pharmaceutical Review is the leading journal for business and technology in the pharmaceutical industry. Offering unbiased editorial on drug delivery, information technology, research & development, analytical development and control, equipment and facility manufacturing and regulatory affairs, American Pharmaceutical Review keeps its users fully abreast of the latest trends and developments in the process of pharmaceutical manufacturing. http://www.americanpharmaceuticalreview.com

About Pharmaceutical Outsourcing

Pharmaceutical Outsourcing is a journal dedicated to pharmaceutical and biopharmaceutical contract services. With regular sections on contract manufacturing, contract research, contract packaging, formulation/development services, contract analytical testing, APIs and other areas, Pharmaceutical Outsourcing provides the most complete coverage of trends and issues in the industry.

http://www.pharmoutsourcing.com/

Share article on social media or email:

Virtuous Woman in Business” is an enjoyable reflection on the virtues that make an effective businesswoman


News Image

“Proverbs 31: Virtuous Woman in Business”: an uplifting message of hope and empowerment. “Proverbs 31: Virtuous Woman in Business” is the creation of published author Linda Ogbah Faas, a native of Nigeria who earned her associate degree in business administration and another associate’s in fire service administration before earning her bachelor’s in communication with a minor in human resources. Faas studied at University of Maryland University College, where she earned her MBA and MS in management and human resources. She is currently a doctoral candidate for her Doctor of Business Administration in leadership. She is a proud mother of two and a Navy veteran who currently serves with the Missouri US Army National Guard.

Faas shares, “As I was reading Proverbs 31 yet again, yearning to learn all I could from this virtuous woman in order to be a better version of myself, it started dawning on me that it has been spoken of and taught to us on how to be a virtuous woman at home, in the church, and in our community. However, not much emphasis has been placed on the business-building entrepreneurial characteristics of the same virtuous woman when every verse in her chapter literally mentions one business or another that she founded or managed. This resonated in me to shine a bright light on all these qualities that were unintentionally underdiscussed. Maybe it was because she was a woman doing business, or maybe we are too accustomed to women being assumed to manage only the home.

“In this day and age, many women manage not just their homes; but they manage businesses, organizations, churches, educational institutes, military units, and much more. In order to represent these modern women, I also needed to point out that women managing businesses did not start with the virtuous woman; it started with the first generation of women that were mentioned in the Bible. As you read the stories of these Bible women and how their daily lives transcend to modern women in our generation, you get to read real life stories of Christian women that have diligently combined the ability of managing their families and their businesses and still kept God first and foremost in their lives—just as the Proverbs 31 virtuous woman did.”

Published by Christian Faith Publishing, Linda Ogbah Faas’s new book will bring clarity to the values and virtues that are found within successful women of faith.

Faas shares in hopes of raising awareness of powerful figures that will aid today’s women through their impressive histories.

Consumers can purchase “Proverbs 31: Virtuous Woman in Business” at traditional brick & mortar bookstores, or online at Amazon.com, Apple iTunes store, or Barnes and Noble.

For additional information or inquiries about “Proverbs 31: Virtuous Woman in Business,” contact the Christian Faith Publishing media department at 866-554-0919.

Share article on social media or email:

Kristina Garcia’s newly released “Awaken My Soul” is an interactive…


“Awaken My Soul” from Christian Faith Publishing author Kristina Garcia is a thoughtful devotional that will engage the spirit and inspire the soul as readers reflect on each carefully structured…

(PRWeb December 15, 2022)

Read the full story at https://www.prweb.com/releases/kristina_garcias_newly_released_awaken_my_soul_is_an_interactive_journaling_experience_that_empowers_readers_to_connect_with_god/prweb19076481.htm

Author Darl Rosenquest’s new book “Science or Science Fiction?” is a thought-provoking work exploring the intersection of Christian faith and the natural world


News Image

Darl Rosenquest, a geologist and civil engineer who worked for over twenty-seven years with the Pennsylvania Department of Environmental Protection as a soils engineer and later a senior civil engineer and has remained active since his retirement in 2015 by helping local conservation districts catch up on plan reviews, presenting at their public workshops, and in training their staff, has completed his new book “Science or Science Fiction? A Geologist Looks at Creation and the Great Flood”: a compelling examination of generally accepted truths from both the scientific record and Scripture.

The author writes, “‘Follow the science’ is a phrase we often hear these days. All too often it means ‘listen to anything coming from the scientific community that supports my position but ignore anything which does not.’ During my lifetime, I have seen a number of changes in many things that were once ‘known’ to be true. For instance, when I was in grade school, it was a commonly believed ‘fact’ that lemmings committed suicide periodically by jumping off a cliff into the ocean. Likewise, everybody knew that ostriches, when confronted with danger, stuck their heads in the sand to hide. More recently, it was believed that the best way to deal with runoff from storms in urban areas was to get the water offsite as quickly as possible, collect it in large detention basins, and then release it slowly into receiving stream channels. The best way to deal with air pollutants, it was thought, was to send it high into the sky to disperse over a large area. Science has since proved that all of these concepts are not true. In this book, I look at some commonly accepted ideas about the origins of the universe and mankind as well as the account of the great flood of Noah. I have attempted to point out where the line between science and science fiction has been blurred, both by the scientific community and the Christian community. If we can learn to distinguish between fact and fiction, perhaps we can come closer to mutual acceptance.”

Published by Page Publishing, Darl Rosenquest’s engrossing book is an intriguing choice for avid Christian readers.

Readers who wish to experience this engaging work can purchase “Science or Science Fiction? A Geologist Looks at Creation and the Great Flood” at bookstores everywhere, or online at the Apple iTunes Store, Amazon, Google Play, or Barnes and Noble.

For additional information or media inquiries, contact Page Publishing at 866-315-2708.

About Page Publishing:

Page Publishing is a traditional, full-service publishing house that handles all the intricacies involved in publishing its authors’ books, including distribution in the world’s largest retail outlets and royalty generation. Page Publishing understands that authors should be free to create, not mired in logistics like eBook conversion, establishing wholesale accounts, insurance, shipping, taxes, and so on. Page’s accomplished writers and publishing professionals allow authors to leave behind these complex and time-consuming issues and focus on their passion: writing and creating. Learn more at http://www.pagepublishing.com.

Share article on social media or email:

Peckham, Inc. Wins Aeroflow Breastpumps’ Pumping Room Makeover


Through this contest, we couldn’t be happier to help create new comfortable, inviting spaces for the incredible mothers who are working for their little ones while also working to help others at Peckham, Inc. each day.

Aeroflow Breastpumps, the leading breast pump distributor and breastfeeding resource center, is thrilled to announce the winner of its fourth annual Pumping Room Makeover Contest: Peckham, Inc., a nonprofit community rehabilitation organization that provides competitive employment opportunities for persons with disabilities in Lansing, Michigan.

The contest, which launched in August 2022, received hundreds of entries from businesses around the U.S. committed to helping people with physical, cognitive, behavioral and socio-economic challenges, Peckham, Inc. was selected as Aeroflow Breastpumps’ $10,000 Grand Prize winner. The nonprofit organization will use the funds to create an entirely new pumping room for its employees and the individuals they serve.

“We were so inspired by the stories Peckham, Inc. has shared with us about their dedicated staff and the work they are doing for the Lansing community,” says Jennifer Jordan, Aeroflow Breastpumps Director of Mom & Baby. “There’s always so much uncertainty that comes with being a new parent, especially when transitioning back to work. Through this contest, we couldn’t be happier to help create new comfortable, inviting spaces for the incredible mothers who are working for their little ones while also working to help others at Peckham, Inc. each day.”

“Right now, our working mothers are using a renovated closet space with lack of ergonomic seating and supplies to pump throughout the work day,” says Maddisen Cardwell-Hutchinson, Vocational Services Specialist at Peckham, Inc. “We couldn’t be more excited or honored to receive Aeroflow Breastpumps’ donation to provide a room where our mothers can escape to decrease stress, increase oxytocin and ultimately make more milk. Every mom deserves a safe space, and we’re thankful to have Aeroflow Breastpumps to help make it happen.”

The Pumping Room Makeover is an annual contest that Aeroflow Breastpumps began in August 2018 in response to an overwhelming amount of feedback from mothers who are tired of nursing and pumping in closets, bathrooms, conference rooms, the car, etc. throughout the workday. These challenging conditions often make it difficult for working moms to produce milk and ultimately forces many to choose between feeding their babies and going back to work. Aeroflow Breastpumps believes that no mother deserves to pump in a bathroom stall and strives to make a difference and create change within the workplace – one pumping room makeover at a time.

About Aeroflow Breastpumps: Aeroflow Breastpumps, a subsidiary of Aeroflow Healthcare, is a Durable Medical Equipment (DME) provider specializing in helping pregnant and nursing women qualify for their breast pump through their insurance. Its mission is to increase the instance of breastfeeding nationally through the best equipment, support and education, and exceptional customer service. Visit AeroflowBreastpumps.com for more information.

About Peckham, Inc.: Peckham is a nonprofit vocational rehabilitation organization that provides paid job training opportunities for people with disabilities and other barriers to employment. For 46 years, Peckham has provided jobs and job skills training to thousands of individuals with barriers through five different business lines throughout Michigan, with additional operations in Phoenix, Arizona and London, Kentucky. Peckham, Inc., is a national award-winning organization, recognized for its achievement in providing exceptional vocational rehabilitation, creating inclusive cultures, and building quality workplaces for employees.

Share article on social media or email:

In 2022, Shady Grove Fertility (SGF) experienced record growth throughout new communities to better serve fertility patients


In 2022, SGF expanded its footprint with 7 new locations and 19 new physicians.

As we reflect on 2022, SGF is most proud of the families who trusted us with their fertility care and allowed us to be a part of their family-building journeys.

Shady Grove Fertility (SGF), a founding partner practice of US Fertility, will close out 2022 by celebrating record growth to better serve patients across the nation. SGF proudly provides comprehensive fertility and family-building care in over 50 convenient locations throughout the U.S. and in Santiago, Chile. Over the last 12 months, SGF expanded its footprint with 7 new locations and 19 new physicians.

SGF is proud to continue increasing access to fertility care throughout the country by opening locations in:


  • Roanoke, Virginia,
  • St. Petersburg, Florida,
  • Spring, Texas,
  • York, Pennsylvania,
  • SoHo and Long Island, New York,
  • and Raleigh, North Carolina.

“SGF puts the patient first,” shares Benjamin Harris, M.D., who provides patient care at SGF’s Richmond and Norfolk, Virginia, locations. “The foundation of our practice is based on doing what is best for our patients, promoting a strong patient-physician relationship, and promoting teamwork through collaborative care. We are constantly striving to improve the care we provide through education, research, and innovation. In doing so, we can enhance the experience of every single patient as we work toward achieving their fertility goals.”    

The SGF physician team welcomed 19 new physicians in 2022:

  • Johanna Archer, V.M.D., M.S., M.D.
  • Stephanie Brownridge, M.D.
  • John R. Crochet Jr., M.D.
  • John M. Csokmay, M.D.
  • Emily A. Evans-Hoeker, M.D.
  • Kathryn C. Humm. M.D.
  • Alexandra Gannon, M.D.
  • Janet Bruno-Gaston, M.D., MSCI
  • Steven Gay, M.D.
  • Amy Lee Harris, M.D.
  • Benjamin S. Harris, M.D., M.P.H.
  • Quinton Katler, M.D., M.Sc.
  • Jennifer E. Mersereau, M.D., MSCI
  • Jerrine R. Morris, M.D., M.P.H.
  • Candice B. O’Hern Perfetto, M.D.
  • Phillip A. Romanski, M.D., M.Sc.
  • Vicki L. Schnell, M.D.
  • Jaimin S. Shah, M.D.
  • Laura X. Zalles, M.D.

“I appreciate that SGF aims to take a complicated and potentially stressful process and make it as straightforward for patients as possible,” shares Dr. Mersereau, who provides patient care at SGF’s Raleigh, North Carolina, location. “This is evident in our high pregnancy rates, our compassionate staff, our Shared Risk 100% Refund program, and our easy access to care.”

Because of SGF’s reputation for providing innovative and compassionate fertility care to patients, over 40 SGF physicians received a Top Doctors recognition from publications throughout the country. The Cade Foundation also honored SGF physician Stephanie Beall, M.D., as a Family Building Champion.    

In line with SGF’s commitment to cutting-edge research, SGF physician scientists presented 19 abstracts and received awards for their research in reproductive medicine at the 2022 American Society for Reproductive Medicine (ASRM) Scientific Congress & Expo. SGF physicians and researchers have been published in several prestigious outlets throughout the year. Recently, Nicole Doyle, M.D., Ph.D., and a team of SGF researchers were published in the Journal of the American Medical Association(JAMA) for their research that assesses the effectiveness of endometrial receptivity analysis (ERA) testing.

SGF physicians have earned the reputation of respected researchers and experts in fertility care. In 2022, several national media outlets sought SGF physicians to shed much-needed light on infertility, affecting one in eight couples trying to conceive. Among them are the following:

  • Isaac Sasson, M.D., Ph.D., spoke with Forbes about ovarian follicles
  • Anate Brauer, M.D., discussed infertility and friendships with Today.com
  • Eric Widra, M.D., reflected on IVF in light of abortion restrictions in The Wall Street Journal
  • Eric D. Levens, M.D., explains adenomyosis to Prevention.com

“As we reflect on 2022, SGF is most proud of the families who trusted us with their fertility care and allowed us to be a part of their family-building journeys,” shares Dr. Widra, Chief Medical Officer at SGF. “We are constantly striving to be the best for our patients and look forward to continuing our patient-first philosophy in 2023 and beyond.”

The upcoming new year marks new beginnings, and for people struggling to conceive, it may be time to consult a fertility specialist. Contact the SGF New Patient Center at 1-888-761-1967 or complete a brief online request form to schedule a virtual fertility consult with an SGF physician. A virtual or in-person consult is the first step toward pursuing a pregnancy with the help of SGF.

About Shady Grove Fertility (SGF)

SGF is a leading fertility and IVF center of excellence with more than 100,000 babies born from 30+ years of continuous innovation and patient-centered fertility care. With over 50 locations throughout the U.S. and in Santiago, Chile, SGF accepts most insurance plans and makes fertility treatment accessible and affordable through innovative financial solutions, including 100% refund guarantees. SGF is among the founding partner practices of US Fertility, the largest physician-owned and physician-led partnership of top-tier fertility practices nationally. Call 1-888-761-1967 to schedule a new patient appointment or visit ShadyGroveFertility.com for more information.

Share article on social media or email:

Focusing on Personalized Medical Care


Aundria and Jim Riggen, co-founders of LX Medical

I have a family myself, so I know all too well how important personalized care is, explains Aundria Riggen, co-founder of LX Medical, a mobile healthcare provider. We go to great lengths to bring back personalized care that people can feel good about.

According to Medical Economics, the general public is not very satisfied with health care in the U.S., and care for older adults ranks even lower. Increasingly, people are looking for alternative ways to meet their healthcare needs, but in a more personalized manner. Rather than being just another number and getting two minutes of the doctor’s time, they want an approach that makes them feel their issues are being better considered and addressed. One company, LX Medical, focuses on giving patients that with their mobile strategy to providing care.

“I have a family myself, so I know all too well how important personalized care is,” explains Aundria Riggen, co-founder of LX Medical, a mobile healthcare provider. “We go to great lengths to bring back personalized care that people can feel good about.”

LX Medical opened during the pandemic out of necessity but realized that it could provide people with better one-on-one care. They have continued their mobile clinic, making house calls for those within a 20-mile radius of downtown Minneapolis. Their team of board-certified health professionals visits people in their homes, providing privacy, convenience, and exceptional care.

They are making medicine more personal, offering such mobile health care services as:


  • Urgent care. They offer house calls for urgent care services, including diagnostic technology, IV fluids, medications, illnesses, ear infections, flu, rashes, wound care, and more.
  • Wellness treatments. IV therapies are available for those with migraines, repair, and recovery, to improve sleep, address aging, recover from colds and flu, and more. They offer a variety of wellness treatments to meet individual needs, including IV vitamin therapy.
  • Direct primary care. Taking a holistic approach to caring for each patient, LX Medical offers on-demand primary care services. They offer individualized attention to help with such issues as routine exams, blood panels, medication management, men’s and women’s health, sleep issues, chronic diseases, and more. They even offer executive physicals.
  • Telemedicine. Available to members and non-members, patients can get a telemedicine appointment for only $59. The appointments can help with everything from basic diagnoses to minor sprains.

“We get such great reviews because it’s an experience that our patients appreciate,” explains Jim Riggen, co-founder of LX Medical. “We built LX around customer service and client satisfaction, something that no other traditional healthcare system was built on. And we will continue to provide people with the care they need and want, where they want it. We are happy to be a part of the healthcare solution.”

LX Medical offers a monthly membership plan that provides members with 24/7 access to mobile urgent care. Membership plans start at $100 per month for adults and $50 per month for children. The mobile medical care services they provide are not limited to illnesses. They also offer wellness care and aesthetics. Patients can get help with migraine treatment, IV vitamin therapy, dermal fillers, and more. The urgent care services include house calls for diagnostic testing, IV fluids, medications, pink eye, viral illnesses, infections, rashes, wound care, and more. They also offer aesthetics options, such as dermal fillers, at their office in Edina, Minn. To learn more about services or to become a member, visit the site at: https://lx-medical.com.

About LX Medical

LX Medical is a Minneapolis-based medical company providing house calls for urgent care, wellness services, and aesthetics. The company was founded by a husband and wife team, Jim and Aundria Riggens. Jim had an advanced practice for nearly 10 years, most of which was dedicated to emergency medicine. Aundria has been a leader in urgent care for over 10 years and has spent three years in orthopedic surgery. To learn more, visit the site at: https://lx-medical.com.

Sources:

Medical Economics. Poll: Less than half of Americans think U.S. health care is handled well. https://www.medicaleconomics.com/view/poll-less-than-half-of-americans-think-u-s-health-care-is-handled-well

Share article on social media or email: